NCT01226290 - Fibroid Ablation Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

LeiomyomaUterine FibroidsMenorrhagia

Interventions

DEVICE

VizAblate System

VizAblate enables a minimally invasive procedure to visualize, target, and ablate uterine fibroids using intrauterine ultrasound and radiofrequency (RF) energy.

Trial Locations (10)

1007

Vrije Universiteit Medisch Centrum, Amsterdam

3430

St. Antonius Ziekenhuis, Nieuwegein

5500

Máxima Medisch Centrum, Veldhoven

64460

Universidad Autonoma de Nuevo Leon (UANL), Monterrey

7513 ER

Medisch Spectrum Twente, Enschede

NW1 2BU

University College Hospital, London

E1 1BB

Royal London Hospital, Whitechapel

B15 2TG

Birmingham Women's NHS Foundation Trust, Birmingham

RH16 3EJ

Princess Royal Hospital, Haywards Health

BD9 6RJ

Bradford Teaching Hospitals NHS Trust, Bradford